Cerep Broadening Services Via $12.9M Acquisition of Hesperion Jan. 21, 2004 By James Etheridge No Comments
Cellectis Licenses Technology To Diversa For Use In Research Jan. 14, 2004 By James Etheridge No Comments
UroGene Licenses Aventis Drug, Engages Third Funding Round Jan. 14, 2004 By James Etheridge No Comments
UroGene Licenses Aventis Drug, Engages Third Funding Round Jan. 14, 2004 By James Etheridge No Comments
Cellectis Licenses Technology To Diversa For Use In Research Jan. 14, 2004 By James Etheridge No Comments
Innogenetics Forms Hepatitis C Union With Roche Diagnostics Jan. 7, 2004 By James Etheridge No Comments
Innogenetics Forms Hepatitis C Union With Roche Diagnostics Jan. 7, 2004 By James Etheridge No Comments
Ariana Seeking EUR5M To Push 'Intelligent' Drug Discovery Dec. 31, 2003 By James Etheridge No Comments
Ariana Seeking EUR5M To Push 'Intelligent' Drug Discovery Dec. 31, 2003 By James Etheridge No Comments
UroGene, SGX To Develop Kinase Inhibitors For Urological Cancers Dec. 24, 2003 By James Etheridge No Comments
